PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
PREDICT
Prognostic Value of Photon-Counting Detector CT-Derived High-Risk Coronary Plaque Features for Predicting Major Adverse Cardiovascular Events: a Prospective Cohort Study
1 other identifier
observational
500
1 country
1
Brief Summary
This prospective cohort study aims to determine whether high-risk coronary plaques identified by novel Photon-Counting Detector CT (PCCT) independently predict future major adverse cardiovascular events (MACE). Participants will be followed for MACE and revascularization. The primary hypothesis is that the incidence of MACE is significantly higher in patients with PCCT-defined high-risk plaque than in those without. Additionally, patients will undergo Optical Coherence Tomography (OCT) and angiography within a month after PCCT; PCCT results will be compared with OCT in a cross-sectional analysis, and diagnostic performance will be evaluated against follow-up data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2025
CompletedFirst Submitted
Initial submission to the registry
July 12, 2026
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2030
September 16, 2026
July 1, 2026
4 years
July 12, 2026
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of major adverse cardiovascular events (MACE)
Incidence of major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, non-fatal myocardial infarction, and hospitalization for unstable angina requiring urgent revascularization, stratified by the presence versus absence of PCCT-defined high-risk plaque.
Up to 24 months
Secondary Outcomes (2)
Per-lesion MACE
Up to 24 months
Myocardial infarction
Up to 24 months
Other Outcomes (1)
Diagnostic accuracy of PCCT for detecting OCT-defined high-risk plaque
up to 12 month
Study Arms (2)
PCCT High-Risk Plaque Group
Participants with PCCT-defined high-risk plaque in at least one native coronary artery. High-risk plaque is defined as the presence of ≥2 of the following features on PCCT: low-attenuation plaque (\<30 Hounsfield Units), positive remodeling (remodeling index ≥1.1), spotty calcification (\<3 mm), and the napkin-ring sign.
PCCT Non-High-Risk Plaque Group
Participants without PCCT-defined high-risk plaque (0 or 1 high-risk feature) in any imaged coronary segment.
Eligibility Criteria
Patient with coronary artery disease
You may qualify if:
- Age ≥18 years
- Scheduled for clinically indicated, non-emergent invasive coronary angiography
- Provision of written informed consent and willingness to comply with long-term follow-up
You may not qualify if:
- Estimated glomerular filtration rate \<45 mL/min/1.73 m²
- Known allergy to iodinated contrast media
- Pregnancy or breastfeeding
- Persistent atrial fibrillation or other arrhythmia precluding adequate ECG-gated CT acquisition
- Body mass index \>40 kg/m²
- Target vessel with a previously implanted stent
- Life expectancy \<2 years or any condition that, in the opinion of the investigator, makes follow-up unlikely or participation inappropriate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Chaoyang Hospital,Capital Medical University, Beijing
Beijing, China, 10000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of the Cardia department
Study Record Dates
First Submitted
July 12, 2026
First Posted
September 16, 2026
Study Start
January 18, 2025
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2030
Last Updated
September 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share